Trichocytes are specialized cells associated with certain venomous animals, particularly in the phylum Cnidaria, which includes jellyfish, anemones, and corals. These cells are part of structures known as nematocysts or cnidocytes, which are responsible for delivering toxins to capture prey or deter predators. Trichocytes have a tubular structure, and each cell contains a long, coiled filament connected to a capsule. When triggered by mechanical or chemical stimuli, the trichocyte rapidly ejects the filament from the capsule, injecting venom into the target organism. The venom typically contains a mix of proteins and toxins that immobilize or incapacitate the prey or threat. In jellyfish, trichocytes are concentrated in the tentacles, where they play a crucial role in capturing and subduing prey. The discharge of nematocysts is a rapid and effective mechanism for jellyfish to secure food. Understanding the structure and function of trichocytes is essential for researchers studying venomous animals and their ecological roles. Additionally, the toxins produced by trichocytes have been of interest in medical research, as they can potentially be used for the development of pharmaceuticals or understanding neurotoxic mechanisms. Overall, trichocytes exemplify the fascinating adaptations that have evolved in certain organisms for survival and predation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy